Art. 2 Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December…

Definitions

In forcesince 7 Aug 2009cited 4×

For the purposes of this Regulation:

(a)

‘medicinal product’ means a medicinal product for human use, as defined in Article 2 of Directive 65/65/EEC;

(b)

‘orphan medicinal product’ means a medicinal product designated as such under the terms and conditions of this Regulation;

(c)

‘sponsor’ means any legal or natural person, established in the Community, seeking to obtain or having obtained the designation of a medicinal product as an orphan medicinal product;

(d)

‘Agency’ means the European Agency for the Evaluation of Medicinal Products.

  • Commission Regulation (EC) No 847/2000 of 27 April 2000 laying down the provisions for i…3Law

    … на настоящия регламент се прилагат определенията, дадени в член 2 от Регламент (ЕО) № 141/2000: „субстанция“ е всяко вещество, …

  • The Medicines (Products for Human Use-Fees) Regulations 20082Law

    … means the person having control of the contract laboratory; “orphan medicinal product” has the meaning given in article 2(b) of Regulation (EC) No. 141/2000 of the European Parliament and of the Council of 16th December 1999 on orphan …

  • Judgment of the General Court (Seventh Chamber) of 22 March 2018. Shire Pharmaceuticals Ireland Ltd v European Medicines Agency.Decision

    … 67), referred to in Article 2(a) of Regulation No 141/2000, read in conjunction with Article 128 of that directive. According to the definition, ‘any substance or combination of substances presented as having properties for treating or …

    22 Mar 2018 · 62016TJ0080

  • The Medicines (Products for Human Use) (Fees) Regulations 20121Law

    … means the person having control of the contract laboratory; “orphan medicinal product” has the meaning given in Article 2(b) of Regulation (EC) No. 141/2000 of the European Parliament and of the Council of 16th December 1999 on orphan …